Skip to content

An Investigation Into a 21-Day Detoxification Diet With a Seven-Day Continuation

An Investigation Into a 21-Day Detoxification Diet With a Seven-Day Continuation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05858476
Enrollment
38
Registered
2023-05-15
Start date
2022-12-02
Completion date
2023-02-20
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Detoxification

Brief summary

Detoxification diets aim to remove chemicals from the body that may cause short or long-term harm. However, little is known about detoxification diets from well-designed clinical trials. This trial examines the efficacy of Chef V's 21-Day Starter Challenge Detox diet. Participants will use Chef V's 21-Day Starter Challenge Detox as directed for the first 21 days of the trial and continue to use the Chef V Green Drink Supplement for an additional seven days. The primary outcomes of interest are the participant's perceptions of their health improvements and biomarkers that will be measured via blood draws.

Interventions

OTHER21-Day Detox and Green Drink supplement

Detox plan description: 7AM Water 16oz. 8AM Green Drink 16oz. 9AM Ultra Shake 16oz. 9-12PM Water 24 - 48oz. 12PM Green Drink 16oz. 12:30 - 2PM Water 24 - 48oz. 2PM Green Drink 16oz. 3PM Ultra Shake 16oz. 3:30- 6PM Water 24 - 48oz. 6PM Green Drink 16oz. 7PM Detox Soup 16oz. 7:30 - 10PM Water 24 - 48oz. This 21-day period will be followed by 7 days of consuming the Green Drink Supplement.

Sponsors

Citruslabs
CollaboratorINDUSTRY
Chef V, LLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
31 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Must be in good general health with no chronic health conditions * BMI under 35. * Must own a scale at home. * Must experience at least one of the following issues: the feeling of being tired at least several times a week, brain fog, sleep issues, trouble with focus and concentration, or having a busy, stressful life. * A subgroup of 10 study participants must be diagnosed with T2D for ≥ 90 days, with an hbA1c of 7.5 to 10.5, inclusive * Eat fast food at least twice a week. * Does not exercise regularly. * Does not consume fruits and vegetables daily. * Must experience at least one of the following gastrointestinal problems: often bloating, excessive gas, heartburn, and irregular bowel movements. * Must experience at least one of the following aches regularly: body aches, joint pain, back pain, or neck pain. * Must be willing to go to Quest labs for two blood draws, one at baseline and the other at the study's conclusion. * Willing to avoid bottled water for the duration of the study.

Exclusion criteria

* Suffers from pre-existing conditions that prevent them from adhering to the protocol. * Anyone with known severe allergic reactions. * Currently pregnant, breastfeeding, or wanting to become pregnant for the duration of the study. * Anyone unwilling to use the test product daily as directed.

Design outcomes

Primary

MeasureTime frameDescription
Changes in participant perceptions of well-being [Time Frame: Baseline to 28 days)28 daysSurvey-based assessment (0-5 scale) of changes in IBS symptoms). Participants will answer surveys at the study baseline, and on Days 5, 11, 21 and 28 of the trial.

Secondary

MeasureTime frameDescription
Change in hs-CRP [Time Frame: Baseline to 28 days]28 daysBlood draws will be taken at Baseline and Day 28 for comparison.
Change in blood lipid profile [Time Frame: Baseline to 28 days]28 daysBlood draws will be taken at Baseline and Day 28 for comparison.
Change in HbA1C [Time Frame: Baseline to 28 days]28 daysBlood draws will be taken at Baseline and Day 28 for comparison.
Change in bodyweight [Time Frame: Baseline to 28 days]28 daysWeight will be measured using an electric scales at the study baseline and on Days 3, 5, 14, and 18.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026